Biologická léčba 2024 I

LOTS


Show detail
DetailN006/24/V00036232/001I. Erenumab (ATC N02CD01)AntineoplastikaNot terminated
DetailN006/24/V00036232/002II. Sekukinumab (ATC L04AC10) AntineoplastikaNot terminated
DetailN006/24/V00036232/003III. Dabrafenib (ATC L01EC02) AntineoplastikaNot terminated
DetailN006/24/V00036232/004IV. Lapatinib (ATC L01EH01)AntineoplastikaNot terminated
DetailN006/24/V00036232/005V. Trametinib (ATC L01EE01)AntineoplastikaNot terminated
DetailN006/24/V00036232/006VI. Ribociklib (ATC L01EF02)AntineoplastikaNot terminated
DetailN006/24/V00036232/007VII. Siponimod (ATC L04AE03)AntineoplastikaNot terminated
DetailN006/24/V00036232/008VIII. Fingolimod (ATC L04AE01)AntineoplastikaNot terminated
DetailN006/24/V00036232/009IX. Ofatumumab (ATC L04AG12) AntineoplastikaNot terminated